Trials / Unknown
UnknownNCT00969098
Response Evaluation in Malignant Pleural Mesothelioma
Early Response Evaluation in Malignant Pleural Mesothelioma By Total Glycolytic Volume (TGV) Analysis of Serial FDG-PET Scans (Positron Emission Tomography Scans)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Istituto Clinico Humanitas · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Recently, a few small trials have shown promising results on value of fluoro-2-deoxy-D-glucose and positron emission tomography imaging in response assessment in Malignant Pleural Mesothelioma. These studies considered different parameters in Positron Emission Tomography (PET) analysis, mainly the standardized uptake value and volume-based parameters such as total glycolytic volume.
Detailed description
This is a retrospective analysis of two consecutive and homogeneous series of Malignant Pleural Mesothelioma patients treated with first-line pemetrexed-based chemotherapy and evaluated by CT scan and FDG-PET.
Conditions
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2015-08-01
- Completion
- 2015-09-01
- First posted
- 2009-08-31
- Last updated
- 2015-08-06
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT00969098. Inclusion in this directory is not an endorsement.